Colon CancerConnect
Treatment of Stage IV- Metastatic or Recurrent Colon Cancer
Genomic testing dictates how precision cancer medicines, chemotherapy & surgery are used to treat advanced colon cancer
Jemperli (dostarlimab) update from ASCO 2022 annual meeting
Jemperli (dostarlimab), a new standard for mismatch repair-deficient locally advanced rectal cancer?
Ask the Experts About Circulating Tumor DNA in the Management of Cancer
Circulating Tumor DNA (ctDNA) detection of Minimal Residual Disease (MRD) is changing the management of colon cancer - NEJM June 2022 Update.
Colon Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Colon Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Colon Cancer Connect is a unique resource that brings patients, caregivers, advocates and experts together in a single community where individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, treatment, and the support of other individuals being treated at some of the best cancer centers. Colon Cancer Connect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey.
Colon Cancer Overviews
Treatment of Stage IV- Metastatic or Recurrent Colon Cancer
Genomic testing dictates how precision cancer medicines, chemotherapy & surgery are used to treat advanced colon cancer
Colorectal Cancer Awareness
The latest information on screening, treatment advances and prevention of Colon and Rectal Cancer.
Treatment & Management of Colon Cancer
Specific treatment for colon cancer is based on the stage and genomic profile of each persons unique colon cancer.
Understanding The CEA Test in Colon, Rectal, Gastric and Other Cancers
CEA blood test can help determine risk and benefit of adjuvant therapy for some patients with early stage colon cancer.
Colon Cancer Treatment
Treatment of Stage IV- Metastatic or Recurrent Colon Cancer
Genomic testing dictates how precision cancer medicines, chemotherapy & surgery are used to treat advanced colon cancer
Jemperli (dostarlimab) update from ASCO 2022 annual meeting
Jemperli (dostarlimab), a new standard for mismatch repair-deficient locally advanced rectal cancer?
Ask the Experts About Circulating Tumor DNA in the Management of Cancer
Circulating Tumor DNA (ctDNA) detection of Minimal Residual Disease (MRD) is changing the management of colon cancer - NEJM June 2022 Update.
Vectibix Delays Progression of Metastatic Colorectal Cancer
The role of Vectibix, KRAS testing and management of associated side effects in advanced colorectal cancer.
Colon Cancer Survivorship
New Research Finds Computer-Assisted Colonoscopy Identifies More Precancerous Polyps Compared to Traditional Colonoscopy
Colonoscopies performed with computer-aided detection increase the overall rate of detection of adenoma, or cancerous and precancerous polyps.
March is Colon Cancer Awareness Month - Survivor Profiles
Learn from Katie Couric and those who beat colon cancer as they share their experiences.
The Gut Microbiome and Cancer Treatment?
Can The Microbiome Influence Treatment Outcomes in Cancer Patients?
Colorectal Cancer Awareness
The latest information on screening, treatment advances and prevention of Colon and Rectal Cancer.